Recent research highlights that BTK inhibition can effectively suppress neuroinflammation and neurodegeneration in amyotrophic lateral sclerosis (ALS). This discovery may pave the way for new therapeutic strategies targeting ALS pathology.
btk inhibition suppresses neuroinflammation and neurodegeneration in amyotrophic lateral sclerosis
Original title: “BTK inhibition suppresses neuroinflammation and neurodegeneration in amyotrophic lateral sclerosis.”